The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pathogenic germline variants in patients with endometrial cancer across diverse ancestries.
 
Ying L. Liu
Research Funding - AstraZeneca (Inst); Repare Therapeutics (Inst); Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Sushmita Gordhandas
No Relationships to Disclose
 
Kanika Arora
No Relationships to Disclose
 
Anna Maio
No Relationships to Disclose
 
Yelena Kemel
No Relationships to Disclose
 
Margaret Sheehan
No Relationships to Disclose
 
Erin E. Salo-Mullen
No Relationships to Disclose
 
Qin Zhou
No Relationships to Disclose
 
Alexia Iasonos
Stock and Other Ownership Interests - Bristol-Myers Squibb/Sanofi
Consulting or Advisory Role - Intelligencia; Mirati Therapeutics
 
Pier Selenica
No Relationships to Disclose
 
Chaitanya Bandlamudi
No Relationships to Disclose
 
Michael F. Berger
Consulting or Advisory Role - AstraZeneca; Lilly; PetDx
Patents, Royalties, Other Intellectual Property - Provisional patent pending for "Systems and Methods for Detecting Cancer via cfDNA Screening"
 
Nadeem Abu-Rustum
Honoraria - NCCN
Research Funding - GRAIL (Inst)
 
Lora H Ellenson
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
Kenneth Offit
Patents, Royalties, Other Intellectual Property - Patent pending on therapeutic applications of targeting ERCC3 mutations in cancer. Diagnosis & treatment of ercc3-mutant cancer US20210137850A1
Other Relationship - AnaNeo Therapeutics
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Genentech/Roche (I); Gyroscope (I); Neurogene (I); Optos (I); Outlook Therapeutics (I); Regeneron (I); Regenxbio (I)
 
Britta Weigelt
Stock and Other Ownership Interests - Repare Therapeutics (I)
Consulting or Advisory Role - Bain Capital Life Sciences (I); Goldman Sachs (I); PAIGE (I); Repare Therapeutics (I); SAGA Diagnostics (I); Volition RX (I)
Research Funding - Repare Therapeutics
 
Carol Aghajanian
Consulting or Advisory Role - AstraZeneca/Merck; Eisai; Repare Therapeutics
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
 
Carol L. Brown
No Relationships to Disclose